Elequin Capital’s CryoPort CYRX Stock Holding History

Elequin Capital’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12	Closed	-$212	–	226
2024 Q1	$212	Buy	+12	New	+$190	﹤0.01%	222
2023 Q3	–	Sell	-16	Closed	-$276	–	447
2023 Q2	$276	Buy	+16	New	+$327	﹤0.01%	510
2022 Q3	–	Sell	-64	Closed	-$2K	–	584
2022 Q2	$2K	Buy	64 +19	+42%	+$505	﹤0.01%	327
2022 Q1	$2K	Buy	+45	New	+$1.7K	﹤0.01%	256

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Elequin Capital's CYRX Position: Q2 2024 in Review

Elequin Capital sold out of CryoPort (CYRX) in Q2 2024, closing a stake of 12 shares — an estimated $212 sold.

Elequin Capital first reported a position in CYRX in Q1 2022 and held it in 4 quarters. The position peaked at $2K in Q2 2022. 159 funds tracked by Wall St. Rank hold CYRX as of Q2 2024.

Elequin Capital reported no remaining CryoPort position as of Q2 2024 after selling out during the quarter.
Elequin Capital sold 12 CryoPort shares in Q2 2024, an estimated $212.
Elequin Capital first reported a position in CryoPort in Q1 2022 and held it in 4 quarters.
Elequin Capital's CryoPort position peaked at $2K in Q2 2022.
159 funds tracked by Wall St. Rank held CryoPort as of Q2 2024.

Based on Elequin Capital's 13F filing for Q2 2024, filed 12 Aug 2024.